+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Drug Analysis: Trelegy Ellipta - Product Thumbnail Image

Drug Analysis: Trelegy Ellipta

  • Drug Pipelines
  • February 2018
  • 16 Pages
  • Global
From
Drug Overview: Cinqair - Product Thumbnail Image

Drug Overview: Cinqair

  • Report
  • February 2018
  • 16 Pages
  • Global
From
Singulair Paediatric - API Insight, 2022 - Product Thumbnail Image

Singulair Paediatric - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Ofev - API Insight, 2022 - Product Thumbnail Image

Ofev - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more